During the past decade, Inselspital Bern; Universitätsklinik für medizinische Onkologie conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inselspital Bern; Universitätsklinik für medizinische Onkologie" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "University Hospital Inselspital, Berne" with 6 trials sponsored, "University of Basel" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Celgene Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inselspital Bern; Universitätsklinik für medizinische Onkologie" #1 collaborator was "Mundipharma Medical Company" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "Anticancer Fund, Belgium" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "BioGene Pharmaceutical Inc." with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Inselspital Bern; Universitätsklinik für medizinische Onkologie" are "Multiple Myeloma" (4 trials), "Non-Small Cell Lung Cancer" (2 trials), "Amyloidosis" (1 trials), "Bladder Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Inselspital Bern; Universitätsklinik für medizinische Onkologie" in a lesser frequency.

Most popular intervention types in "Inselspital Bern; Universitätsklinik für medizinische Onkologie" are "Drug" (18 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Gemcitabine" (3 trials), "Bendamustine" (2 trials), "Paclitaxel" (2 trials) and "Tiragolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Inselspital Bern; Universitätsklinik für medizinische Onkologie" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Inselspital Bern; Universitätsklinik für medizinische Onkologie". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Inselspital Bern; Universitätsklinik für medizinische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inselspital Bern; Universitätsklinik für medizinische Onkologie, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".